FDA: Serious Complications Associated With Surgical Mesh for Transvaginal Repair of POP are Not Rare
The U.S. Food and Drug Administration has issued an update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (POP), indicating these ...
Please provide your email address to receive an email when new articles are posted on . Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, ...
The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results